A biotechnology company focused on developing RNA interference (RNAi) therapeutics that silence disease-causing genes. Its approved drugs target rare genetic conditions, including hereditary transthyretin-mediated amyloidosis, while a broader pipeline spans cardiometabolic, hepatic, and neurologic d...
6 members of Congress have disclosed 20 trades in Alnylam Pharmaceuticals, Inc. (ALNY), a Healthcare company. The buy/sell breakdown shows 10 purchases versus 10 sales. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-05-12 | Jefferson Shreve | sell | $15K – $50K |
| 2024-05-14 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2024-01-29 | Josh Gottheimer | sell | $1K – $15K |
| 2024-01-11 | Josh Gottheimer | buy | $1K – $15K |
| 2023-12-11 | Josh Gottheimer | sell | $1K – $15K |
| 2023-03-06 | Daniel Goldman | buy | $15K – $50K |
| 2023-01-31 | Daniel Goldman | sell | $15K – $50K |
| 2022-09-28 | Josh Gottheimer | buy | $1K – $15K |
| 2020-11-13 | Josh Gottheimer | sell | $1K – $15K |
| 2020-04-06 | Josh Gottheimer | buy | $1K – $15K |
| 2020-03-12 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2018-10-18 | Josh Gottheimer | sell | $1K – $15K |
| 2018-06-01 | Josh Gottheimer | buy | $1K – $15K |
| 2018-03-05 | Barbara J Honorable Comstock | sell | $15K – $50K |
| 2017-10-12 | Barbara J Honorable Comstock | buy | $15K – $50K |
| 2016-12-30 | Richard L. Hanna | sell | $1K – $15K |
| 2016-12-30 | Richard L. Hanna | buy | $50K – $100K |
| 2016-12-13 | Richard L. Hanna | sell | $100K – $250K |
| 2016-10-13 | Richard L. Hanna | buy | $100K – $250K |
| 2016-08-26 | MICHAEL T. MCCAUL | buy | $50K – $100K |